The 36th Annual Meeting of the Society for Medical Decision Making: Author Index M

Author Index: M

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Ma, W. W.

• REGORAFENIB USE IN METASTATIC COLORECTAL CANCER AFTER FAILING ALL APPROVED LINES OF THERAPY: ADEQUATE QUALITY OF LIFE AND COST-EFFECTIVE?

MacAulay, C.

• DNA PLOIDY ANALYSIS IS A COST-EFFECTIVE ALTERNATIVE FOR CERVICAL SCREENING

Machta, R.

• EXAMINING THE EFFECTIVENESS OF DIFFERENT ELEMENTS OF A READMISSION PREVENTION BUNDLE

Maciejewski, M.

• USE OF CLINICAL PATHWAYS RESULTED IN LOWER IMAGING RATES FOR A MEDICARE POPULATION

• CALIBRATION OF PIECEWISE MARKOV MODELS USING A BAYESIAN CHANGE-POINT ANALYSIS THROUGH AN ITERATIVE CONVEX OPTIMIZATION ALGORITHM

Madadi, M.

• OPTIMIZING BREAST CANCER MAMMOGRAPHY SCREENING POLICIES CONSIDERING WOMEN'S ADHERENCE BEHAVIORS

Madden, V.

• THINKING FORWARD: THE TIME ORIENTATION OF PATIENTS MAKING TREATMENT DECISIONS

Magid, S.

• PERCEPTION OF SURGICAL SITE INFECTION RISK FACTORS FOR SPINE SURGERY VARIES BY OPERATIVE TEAM ROLE

Magnan, S.

• “IT'S LIKE JAYWALKING ACROSS A BUSY STREET WITH YOUR EYES CLOSED, YOU'RE TAKING A CHANCE”: RISK COMMUNICATION AND VALUES CLARIFICATION IN A RADIATION ONCOLOGY CLINIC

Magoc, E.

• DECREASING VETERANS DESIRE FOR EARLY REPEAT COLONOSCOPIES

Maillart, L.

• MEDICAL DECISION MAKING PROBLEMS WITH LARGE POLICY SPACES: WHY MARKOV DECISION PROCESSES TRUMP SIMULATION
• MARKOV DECISION PROCESSES - ANALYTIC METHODS FOR SEQUENTIAL DECISIONS

Mak, E.

• GEOGRAPHIC VARIATION IN RESPONSE TO FDA WARNINGS: EVIDENCE FROM A NATIONALLY INTEGRATED SYSTEM

Málaga, G.

• PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS
• PERSPECTIVES AND DECISION MAKING REGARDING THE MODE OF DELIVERY IN PREGNANT WOMEN WITH A PREVIOUS C-SECTION IN A GENERAL HOSPITAL IN LIMA, PERU

Malhotra, C.

• *TOP RANKED ABSTRACT AT THE 2014 ASIA - PACIFIC CONFERENCE* CONCORDANCE IN PREFERENCES FOR END OF LIFE CARE BETWEEN ADVANCED CANCER PATIENTS AND THEIR CAREGIVERS IN SINGAPORE: A DISCRETE CHOICE EXPERIMENT

Maniet, B.

• USE OF A PERSONALIZED MEDICINE, GENE EXPRESSION SCORE INFLUENCED DECISION MAKING AROUND REFERRAL TO CARDIOLOGY AMONG FEMALE PATIENTS PRESENTING TO PRIMARY CARE WITH SYMPTOMS SUGGESTIVE OF OBSTRUCTIVE CORONARY ARTERY DISEASE

Manuel, D.

• COST-EFFECTIVENESS ANALYSIS OF PALLIATIVE TEAM CARE FOR PATIENTS NEARING END-OF-LIFE

Marang-van de Mheen, P. J.

• REASONS FOR ORTHOPAEDIC SURGEONS TO PROVIDE RECOMMENDED NON-SURGICAL TREATMENTS TO PATIENTS WITH HIP OR KNEE OSTEOARTHRITIS

• A CULTURALLY-TAILORED BROCHURE TO IMPROVE UNDERSTANDING AMONG WOMEN WITH AN INCOMPLETE MAMMOGRAM RESULT

Marra, C. A.

• DOES INTRODUCING IMPRECISION AROUND PROBABILITIES FOR BENEFIT AND HARM INFLUENCE THE WAY PEOPLE VALUE TREATMENTS?

• BEYOND SEQUENCING FOR MEDICAL PRACTICE PATTERN ANALYSIS: THE USE OF HIERARCHICAL CLUSTER ANALYSIS WITH AN APPLICATION TO URETEROLITHIASIS

Martin, J.

• TRANSLATING KNOWLEDGE INTO POLICY: THE CASE OF VALUE BASED INSURANCE DESIGN

• SOCIAL NORMATIVE BELIEFS ARE CENTRAL TO PATIENT CHOICE TO INTENSIFY THERAPY IN RHEUMATOID ARTHRITIS

Mason, J.

• A COST COMPARISON ANALYSIS OF TWO LABORATORY ANALYTIC METHODS FOR BLOOD LEAD LEVELS IN YOUNG CHILDREN, RICHMOND, VA

Mason, J. E.

• COST AND COMPARATIVE EFFECTIVENESS OF A GENOMIC CLASSIFIER FOR PROSTATE CANCER TREATMENT DECISIONS

Mathews, B.

• GAME-IFIED ONLINE LEARNING MODULE FOR REPORTING SUSPECTED CHILD ABUSE

Matlock, D.

• EVIDENCE OF COGNITIVE BIAS IN DECISION MAKING AROUND IMPLANTABLE-CARDIOVERTER DEFIBRILLATORS: A QUALITATIVE FRAMEWORK ANALYSIS

• VALUING PREFERENCES FOR THE PROCESS AND OUTCOME OF CLINICAL GENETICS SERVICES: A PILOT STUDY

McCabe, C.

• ADVANCING METHODS OF HTA: OPTIMISING MONITORING TESTS TO MEET VALUE TARGETS

McCabe, C.

• STEM CELL DERIVED BETA CELL TRANSPLANTATION: AN EXAMPLE FOR MODELLING THE COST OF MANUFACTURING NEW AND IMMATURE HEALTHCARE TECHNOLOGIES FOR EARLY PRIORITIZATION OF RESEARCH AND RESOURCES

McCarthy, E. P.

• COLON CANCER SCREENING AMONG US ADULTS AGED 65 AND OLDER: THE INFLUENCE OF LIFE EXPECTANCY AND AGE

McCaskill-Stevens, W.

• “MY LIVED EXPERIENCES ARE MORE IMPORTANT THAN YOUR PROBABILITIES”: DECISION NARRATIVES IN THE STUDY OF TAMOXIFEN AND RALOXIFENE (STAR)

• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• FINDINGS FROM A SYSTEMATIC REVIEW OF ALTERNATE STRATEGIES FOR COMMUNICATING THE UNCERTAINTY OF MEDICAL EVIDENCE
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?

• USABILITY TESTING OF “INFORMEDTOGETHER”, A WEB-BASED DECISION AID TO FACILITATE SHARED ADVANCE DIRECTIVE PLANNING FOR SEVERE COPD

• SYSTEMATIC REVIEW AND META-ANALYSIS OF DIRECTLY OBSERVED THERAPY FOR TREATMENT OF HEPATITIS C

McElroy, L.

• COST MINIMIZATION OF AFTER HOURS POSTOPERATIVE CARE FOR TRANSPLANT RECIPIENTS

McKell, D.

• IMPROVING PHYSICIAN DECISION-MAKING TO REDUCE RISK EXPOSURE
• SIMULATION TRAINING TO IMPROVE CLINICAL DECISION-MAKING BY SURGICAL RESIDENTS

McKenzie, F.

• A COMPARISON OF NEONATAL MORBIDITY AND MORTALITY ESTIMATES PROVIDED BY OBSTETRICIANS AND NEONATOLOGISTS IN PERIVIABLE COUNSELING
• USING CONJOINT ANALYSIS TO ASSESS THE RELATIVE INFLUENCE OF RESUSCITATION PREFERENCES ON OBSTETRICAL MANAGEMENT OF PERIVIABLE DELIVERIES

• HAS MY PATIENT RESPONDED TO TREATMENT? THE SELDOM ASKED QUESTION IN PERSONALIZED MEDICINE RESEARCH
• TRADING OFF BENEFIT AND RISK OF SIDE EFFECTS FOR PERSONALIZED MEDICINE? A CONJOINT ANALYSIS STUDY

Mehta, R.

• COST EFFECTIVENESS OF THE NEW MEDICINE SERVICE IN COMMUNITY PHARMACIES IN ENGLAND

Mello, S.

• TAILORING, EXEMPLARS, AND AMOUNT OF INFORMATION IN AN ONLINE MAMMOGRAPHY DECISION AID: EFFECTS ON DECISION PROCESS OUTCOMES

• PATTERNS OF COST-RELATED MEDICATION NON-ADHERENCE AMONG OLDER PATIENTS AT HIGH RISK OF HOSPITALIZATION
• PATIENT-SPECIFIC PHARMACOGENOMIC RESULTS DELIVERED VIA A GENOMIC PRESCRIBING DECISION SUPPORT SYSTEM STRONGLY INFLUENCE PHYSICIAN MEDICATION DECISION-MAKING AND PRESCRIBING BEHAVIORS
• SYMPOSIUM: SO A MODELER, AN ECONOMIST, A SHARED DECISION MAKING EXPERT AND A PAIR OF PATIENT EXPERTS WALK INTO A CONFERENCE ROOM...
• FINANCIAL BURDEN AND IMPOVERISHMENT DUE TO CARDIOVASCULAR MEDICINES IN LOW AND MIDDLE INCOME COUNTRIES, AN ANALYSIS WITH ILLUSTRATION FROM INDIA
• COMPARING EVIDENCE-BASED DECISION TOOLS TO CHECKLISTS FOR THE PREVENTION OF HOSPITAL-ACQUIRED CONDITIONS: A VALUE OF INFORMATION ANALYSIS

Melvin, C.

• STRENGTH OF EVIDENCE FOR STRATEGIES USED TO DISSEMINATE MEDICAL EVIDENCE TO CLINICIANS AND PATIENTS
• FINDINGS FROM A SYSTEMATIC REVIEW OF ALTERNATE STRATEGIES FOR COMMUNICATING THE UNCERTAINTY OF MEDICAL EVIDENCE
• WHICH COMMUNICATION STRATEGIES IMPACT THE EFFECTIVENESS OF MESSAGES ABOUT MEDICAL EVIDENCE?

Mendez, C.

• PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS

Mennemeyer, S. T.

• MODELING DEPRESSION TREATMENT STRATEGIES FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTED (HIV+) PATIENTS USING AGENT-BASED MODELING

Merlin, T.

• ASSESSING THE COST-EFFECTIVENESS OF HBA1C TESTING IN THE DIAGNOSIS OF TYPE II DIABETES AND THE IMPACT OF AN IMPERFECT DIAGNOSTIC REFERENCE STANDARD

Mermin, J.

• HIV SEXUAL TRANSMISSION RISK: ASSESSING THE EFFECTS OF COMBINING PREVENTION STRATEGIES

Messonnier, M. L.

• THE MARGINAL COST-EFFECTIVENESS OF CHILDHOOD VACCINATION COVERAGE

Meyer, L. A.

• PARENTAL RISK PERCEPTION AND DECISION MAKING REGARDING VACCINATION OF THEIR ELIGIBLE CHILDREN WITH THE HUMAN PAPILLOMAVIRUS VACCINE

Mhaskar, R.

• UNCERTAINTY ABOUT EFFECTS IS A KEY FACTOR INFLUENCING INSTITUTIONAL REVIEW BOARDS' APPROVAL OF CLINICAL STUDIES

• TIMING OF DECISIONS TO ADJUST DISEASE MODIFYING ANTI-RHEUMATIC DRUG THERAPY FOR RHEUMATOID ARTHRITIS PATIENTS WITH ACTIVE DISEASE

• RISK STRATIFICATION USING CSF BIOMARKERS IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT-AN EXPLORATORY ANALYSIS
• USING BIOMARKER TESTING TO TARGET TREATMENT TO PATIENTS WITH MILD COGNITIVE IMPAIRMENT AT INCREASED RISK OF ALZHEIMER'S DISEASE

Miladinovic, B.

• UNCERTAINTY ABOUT EFFECTS IS A KEY FACTOR INFLUENCING INSTITUTIONAL REVIEW BOARDS' APPROVAL OF CLINICAL STUDIES

Mills, M.

• RETURN ON INVESTMENT OF A WORK-FAMILY INTERVENTION: EVIDENCE FROM THE WORK, FAMILY, AND HEALTH NETWORK

• CLASSIFYING PATIENTS ON THE PROBLEM SOLVING DECISION MAKING SCALE WITH LATENT CLASS ANALYSIS

• GAME-IFIED ONLINE LEARNING MODULE FOR REPORTING SUSPECTED CHILD ABUSE

Minhas, R.

• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE

Miraldo, M.

• JOURNEY TO VACCINATION: A QUALITATIVE EXPLORATION OF HOW BELIEFS, PERCEPTIONS AND PREVIOUS EXPERIENCES INFLUENCE VACCINATION BEHAVIOR

Mirelman, A.

• ESTIMATED HEALTH AND ECONOMIC IMPACT OF IMMUNIZATION AGAINST VACCINE-PREVENTABLE DISEASES RELATED TO TEN ANTIGENS IN 73 COUNTRIES DURING THE DECADE OF VACCINES (2011-2020)

Miron-Shatz, T.

• A TAILORED APPROACH TO RISK COMMUNICATION IN DECISION AIDS: FINDING THE OPTIMAL FORMAT FOR INDIVIDUALS

Mishra, M.

• COMPARING EVIDENCE-BASED DECISION TOOLS TO CHECKLISTS FOR THE PREVENTION OF HOSPITAL-ACQUIRED CONDITIONS: A VALUE OF INFORMATION ANALYSIS

Mitchell, A.

• CLINICAL DECISION RULES UBIQUITOUS TO THE EMERGENCY CARE SETTING ARE NOT EFFECTIVE IN RESOLVING THE BURDEN OF UNNECESSARY CT IMAGING IN WOMEN EVALUATED FOR PULMONARY EMBOLISM

Mitchell, I.

• WHY DON'T END-OF-LIFE CONVERSATIONS GO VIRAL? A SYSTEMATIC REVIEW OF YOUTUBE

• ANALYSIS OF HEALTHCARE COSTS IN PATIENTS WITH ACUTE WHIPLASH-ASSOCIATED DISORDERS USING ZERO-ADJUSTED GAMMA MODELS
• WOUND INTERDISCIPLINARY TEAMS (WIT): A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL
• IMPLEMENTATION CHALLENGES OF A COMMUNITY-BASED PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN WOUND CARE
• COST EFFECTIVENESS ANALYSIS OF SYSTEMATIC REFERRAL TO MULTIDISCIPLINARY WOUND CARE TEAMS IN ONTARIO. EVIDENCE FROM THE WOUND INTERDISCIPLINARY TEAMS (WIT) TRIAL

Mittmann, N.

• THE ECONOMIC IMPACT OF CLOSTRIDIUM DIFFICILE: A SYSTEMATIC REVIEW

Moehling, K.

• A 2-YEAR RANDOMIZED CLUSTER TRIAL TO IMPROVE CHILDHOOD INFLUENZA VACCINATION

Moher, E.

• GET IT RIGHT OR OBTAIN IT CORRECTLY: THE ROLE OF READABILITY OF CONSENT FORMS IN DETERMINING DISCLOSURE RATES

Monane, M.

• USE OF A PERSONALIZED MEDICINE, GENE EXPRESSION SCORE INFLUENCED DECISION MAKING AROUND REFERRAL TO CARDIOLOGY AMONG FEMALE PATIENTS PRESENTING TO PRIMARY CARE WITH SYMPTOMS SUGGESTIVE OF OBSTRUCTIVE CORONARY ARTERY DISEASE

• PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS

Montaner, J.

• DYNAMICS IN THE COSTS OF CRIMINALITY AMONG OPIOID DEPENDENT INDIVIDUALS

Montero, A.

• COST-EFFECTIVENESS ANALYSIS OF METASTATIC BREAST CANCER TREATMENTS: A STUDY BASED ON THE BOLERO-2 TRIAL
• APPLICATION OF MULTI-CRITERIA DECISION ANALYSIS IN HEALTHCARE: A SYSTEMATIC REVIEW OF THE LITERATURE

Montie, J.

• WHAT ARE THE PUBLIC HEALTH IMPLICATIONS OF NEW BIOMARKERS FOR PROSTATE CANCER SCREENING?

• PREFERENCES AND PERCEPTIONS OF DECISION-MAKING MODELS BY PERUVIAN MEDICAL STUDENTS

Moore, C.

• CLINICAL DECISION RULES UBIQUITOUS TO THE EMERGENCY CARE SETTING ARE NOT EFFECTIVE IN RESOLVING THE BURDEN OF UNNECESSARY CT IMAGING IN WOMEN EVALUATED FOR PULMONARY EMBOLISM

Moore, K.

• ETHNIC, GENDER, AND MARITAL STATUS DISPARITIES OF THE BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: NHANES (1999-2012)
• BURDEN OF CANCER-ATTRIBUTABLE INFECTIONS IN THE US: ANALYSIS FROM NATIONAL POPULATION-BASED SURVEYS (1999-2012)

• CLASSIFYING PATIENTS ON THE PROBLEM SOLVING DECISION MAKING SCALE WITH LATENT CLASS ANALYSIS

• INFORMATION NEEDS OF DECISION-MAKERS IN HEALTHCARE: REDUCING THE KNOWLEDGE TO ACTION GAP

Morgan, T.

• WHAT ARE THE PUBLIC HEALTH IMPLICATIONS OF NEW BIOMARKERS FOR PROSTATE CANCER SCREENING?

Morona, J.

• ASSESSING THE COST-EFFECTIVENESS OF HBA1C TESTING IN THE DIAGNOSIS OF TYPE II DIABETES AND THE IMPACT OF AN IMPERFECT DIAGNOSTIC REFERENCE STANDARD

Morris, C.

• THE CORRELATION BETWEEN THREE MORTALITY INDICES TO DETERMINE THE LIKELIHOOD OF BENEFIT FROM COLORECTAL CANCER SCREENING IN COMMUNITY-DWELLING OLDER ADULTS
• TESTING A COLORECTAL CANCER SCREENING DECISION AID TARGETED TO OLDER ADULTS

Morris, N.

• PREDICTORS OF BEHAVIORAL INTERVENTION ATTENDANCE AND CLINICAL APPOINTMENT SHOW RATE FOR INDIVIDUALS WITH SERIOUS MENTAL ILLNESS AND DIABETES

Morris, S.

• ESTIMATING THE HEALTHCARE COSTS ATTRIBUTABLE TO INVASIVE MENINGOCOCCAL DISEASE

Moy, B.

• STABILITY OF BREAST CANCER PATIENTS' KNOWLEDGE, GOALS AND DECISION MAKING PROCESS AROUND BREAST RECONSTRUCTION: DOES WHEN YOU ASK MATTER?

Mugavero, M.

• MODELING DEPRESSION TREATMENT STRATEGIES FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTED (HIV+) PATIENTS USING AGENT-BASED MODELING

Mühlberger, N.

• THE ONCOTYROL PROSTATE CANCER OUTCOME AND POLICY MODEL - LESSONS LEARNED FROM NATURAL HISTORY CALIBRATION
• *TOP RANKED ABSTRACT AT THE 15TH BIENNIAL EUROPEAN MEETING* COMBINING MARKOV STATES: A COMPARISON OF ANALYTICAL AND HEURISTIC METHODS FOR DERIVING THE HAZARD RATES OF A COLLAPSED MARKOV STATE

Muka, A.

• WHEN IS ENOUGH EVIDENCE ENOUGH? VALUE-OF-INFORMATION ANALYSIS FOR PRIORITIZING ADDITIONAL OUTCOMES RESEARCH ON THE TREATMENT OF CHRONIC MYELOID LEUKEMIA

Mundy, M.

• GAME-IFIED ONLINE LEARNING MODULE FOR REPORTING SUSPECTED CHILD ABUSE

Munro, S.

• USABILITY TESTING OF A PATIENT EDUCATION TOOL FOR VAGINAL BIRTH AFTER CESAREAN (VBAC)

Muriello, P. F.

• PRESENTING STOOL TESTING AS THE DEFAULT OPTION FOR COLORECTAL CANCER SCREENING: RESULTS OF A RANDOMIZED TRIAL

Murray, P.

• PARENTS BURDEN OF PEDIATRIC INFLUENZA AS A CAREGIVER AND THEIR EXPECTATION TO RECEIVE ANTIBIOTIC PRESCRIPTIONS FOR THEIR CHILDREN – A PILOT STUDY AT A PEDIATRIC CLINIC

Murthy, S.

• IMPACT OF INSURANCE STATUS ON OUT-OF-POCKET COST FOR U.S. INDIVIDUALS WITH STROKE

• EXTRACTING OPERATING CHARACTERISTICS THAT ARE “BAKED INTO” DISEASE ASSOCIATION MEASURES

• COST-EFFECTIVENESS OF NOVEL HEPATITIS C REGIMENS IN THE VETERANS HEALTH ADMINISTRATION

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z